Legal Battle Between UCSD, USC Continues

The University of Southern California countersues the University of California, San Diego, as a pharmaceutical company ends an Alzheimer’s research–related contract with the latter institution.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The George Finley Bovard building on the campus of USCWIKIMEDIA, BRION VIBBERThe legal dispute between the University of Southern California (USC) and the University of California, San Diego (UCSD), is showing no signs of resolution. Last month (August 24), a San Diego Superior Court Judge issued a preliminary injunction that would force USC to cede control of a multi-million-dollar Alzheimer’s project that a former UCSD researcher took with him when he moved institutions. And as the two sides await the formal court order granting the injunction, USC countersued UCSD for trying to intimidate researchers who also wanted to leave UCSD for USC with principal investigator Paul Aisen, among other allegations.

“The University of Southern California’s cross-complaint is fundamentally dishonest,” UCSD said in a statement. “It is a collection of misstatements and outright falsehoods designed to distract from a singular truth: While he was on the faculty at UC San Diego, Dr. Paul Aisen, aided and abetted by his future employer USC, illegally seized control of data and computer systems that belong to UC San Diego as the administrator of the Alzheimer’s Disease Cooperative Study (ADCS).”

In its countersuit, USC is claiming that UCSD tried to force Aisen to sign an oath of loyalty prior to his departure from UCSD to USC in June. The suit also alleges that UCSD defamed Aisen by telling pharmaceutical industry sponsors of ADCS that Aisen had committed crimes and was ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026, Issue 1

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs
Graphic of three DNA helices in various colors

An Automated DNA-to-Data Framework for Production-Scale Sequencing

illumina
Exploring Cellular Organization with Spatial Proteomics

Exploring Cellular Organization with Spatial Proteomics

Abstract illustration of spheres with multiple layers, representing endoderm, ectoderm, and mesoderm derived organoids

Organoid Origins and How to Grow Them

Thermo Fisher Logo

Products

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control

Biotium Logo

Biotium Launches GlycoLiner™ Cell Surface Glycoprotein Labeling Kits for Rapid and Selective Cell Surface Imaging

Colorful abstract spiral dot pattern on a black background

Thermo Scientific X and S Series General Purpose Centrifuges

Thermo Fisher Logo
Abstract background with red and blue laser lights

VANTAstar Flexible microplate reader with simplified workflows

BMG LABTECH